| PRODUCT NAME | HOLDER | STATUS | DATE | INDICATION |
|---|
| Clopidogrel / Acetylsalicylic acid Viatris (previously Clopidogrel / Acetylsalicylic acid Mylan) | Mylan Pharmaceuticals Limited | Authorised | 09/01/2020 | Acute Coronary Syndrome;Myocardial Infarction |
| DuoPlavin | Sanofi Winthrop Industrie | Authorised | 14/03/2010 | Acute Coronary Syndrome;Myocardial Infarction |
| Clopidogrel/Acetylsalicylic acid Zentiva (previously DuoCover) | Sanofi-Aventis Groupe | Authorised | 14/03/2010 | Acute Coronary Syndrome;Myocardial Infarction |
| Clopidogrel/Acetylsalicylic acid Teva | Teva Pharma B.V. | Withdrawn | 01/09/2014 | Acute Coronary Syndrome;Myocardial Infarction |
| DuoPlavin | Sanofi Pharma Bristol-Myers Squibb | Application withdrawn | | Vascular Surgical Procedures;Peripheral Vascular Diseases;Myocardial Infarction;… |
| DuoCover | Bristol Myers Squibb Pharma EEIG | Application withdrawn | | Vascular Surgical Procedures;Peripheral Vascular Diseases;Myocardial Infarction;… |